バイオ医薬品ロジスティクス市場- 世界の産業規模、シェア、動向、機会、予測、サービス別、業務タイプ別地域別セグメント、競合、2020-2030F

バイオ医薬品ロジスティクスの世界市場規模は2024年に803億6,000万米ドルとなり、予測期間では2030年までCAGR 7.16%で堅調な成長が予測されています。

世界のバイオ医薬品ロジスティクス市場は、製薬およびバイオテクノロジー産業において重要な役割を果たす、ダイナミックで急速に発展している分野です。ワクチン、医薬品、生物製剤、臨床試験材料を含むバイオ医薬品の保管、輸送、流通の計画、実行、管理を包含します。この市場は、バイオ医薬品に対する需要の増加、医薬品サプライチェーンの世界化、機密性の高いバイオ医薬品の完全性を維持するための特殊な温度管理と時間的制約のあるロジスティクス・ソリューションの必要性など、いくつかの重要な要因によって牽引されています。

バイオ医薬品ロジスティクス世界市場の主な促進要因の一つは、バイオ医薬品に対する需要の高まりです。バイオテクノロジーや製薬研究の進歩により、より複雑で個別化された医薬品の開発が進む中、これらの製品を輸送・保管するための信頼性が高く効率的なロジスティクスサービスの必要性が最も高まっています。COVID-19パンデミックは、ワクチンや治療薬を世界規模でタイムリーに届けるための強固なサプライチェーンの重要性を浮き彫りにしました。

主な市場促進要因

バイオ医薬品需要の増加

主な市場課題

温度管理とモニタリング

主な市場動向

温度制御物流

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のバイオ医薬品ロジスティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サービス別（輸送、倉庫・配送、付加価値サービス）
  • 業務種別（コールドチェーン、非コールドチェーン）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • サービス別
  • 手術の種類別
  • 地域別

第5章 アジア太平洋地域のバイオ医薬品ロジスティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サービス別
  • 手術の種類別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州のバイオ医薬品ロジスティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米のバイオ医薬品ロジスティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米のバイオ医薬品ロジスティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカのバイオ医薬品ロジスティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界のバイオ医薬品ロジスティクス市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Kerry Logistics Network Limited
• Deutsche Post AG
• DHL Group
• Kuehne+Nagel International AG
• UPS（Marken）Inc.
• DB Schenker
• FedEx Corp.
• Nippon Express Co Ltd
• World Courier Inc.
• SF Express

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Bio-Pharma Logistics Market was valued at USD 80.36 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 7.16% through 2030. The Global Bio-Pharma Logistics Market is a dynamic and rapidly evolving sector that plays a critical role in the pharmaceutical and biotechnology industries. It encompasses the planning, execution, and management of the storage, transportation, and distribution of biopharmaceutical products, including vaccines, pharmaceuticals, biologics, and clinical trial materials. This market is driven by several key factors, including the increasing demand for biopharmaceutical products, the globalization of the pharmaceutical supply chain, and the need for specialized temperature-controlled and time-sensitive logistics solutions to maintain the integrity of sensitive biopharmaceutical products.

One of the major drivers of the Global Bio-Pharma Logistics Market is the growing demand for biopharmaceutical products. As advancements in biotechnology and pharmaceutical research lead to the development of more complex and personalized medicines, the need for reliable and efficient logistics services to transport and store these products is paramount. COVID-19 pandemic has underscored the importance of a robust supply chain to ensure the timely delivery of vaccines and therapeutic drugs on a global scale.

Key Market Drivers

Increasing Demand for Biopharmaceutical Products

The increasing demand for biopharmaceutical products is a pivotal factor driving the growth of the Global Bio-Pharma Logistics Market. Biopharmaceuticals, which include vaccines, monoclonal antibodies, gene therapies, and other advanced therapeutic modalities, have gained significant traction in recent years due to their remarkable efficacy in treating a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. This surge in biopharmaceutical development has catalyzed a corresponding need for efficient and specialized logistics solutions to ensure that these products are manufactured, transported, and distributed seamlessly across the globe. For instance, according to data from the Medical Logistics Branch of the China Federation of Things, the cold vaccine chain market in 2021 was valued at approximately CNY 48.14 billion (USD 7 billion), reflecting a year-on-year growth of 23.3%. In recent years, China has heavily invested in enhancing the development of cold vaccine chains and nationwide traceability systems.

Key Market Challenges

Temperature Control and Monitoring

Temperature control and monitoring pose a significant challenge to the Global Bio-Pharma Logistics Market. Biopharmaceutical products, including vaccines, biologics, gene therapies, and other advanced therapeutics, are highly sensitive to temperature fluctuations. Ensuring that these products are transported and stored under precise temperature conditions is essential to maintain their integrity, safety, and efficacy. The inability to address this challenge effectively can have far-reaching consequences for both the pharmaceutical industry and patient health.

One of the primary issues facing the bio-pharma logistics sector is the need for maintaining a consistent temperature throughout the entire supply chain. These products often require stringent temperature control, with variations outside the specified range potentially rendering them ineffective or even dangerous to patients. Achieving this level of temperature control presents several challenges.

The transportation of biopharmaceuticals involves a complex and multifaceted network of providers, including manufacturers, carriers, distribution centers, and healthcare facilities. Each of these entities must adhere to strict temperature requirements to ensure product quality. Any lapse in temperature control at any point along the supply chain can jeopardize the safety and efficacy of the products.

Key Market Trends

Temperature-Controlled Logistics

Temperature-controlled logistics plays a pivotal role in boosting the Global Bio-Pharma Logistics Market. This key trend addresses one of the most critical challenges facing the pharmaceutical and biotechnology sectors: the need to ensure the safe and effective transportation of temperature-sensitive biopharmaceutical products. As the demand for vaccines, biologics, gene therapies, and other advanced therapeutic modalities continues to grow, the necessity for maintaining precise temperature conditions throughout the supply chain has never been more significant. For instance, India ranks among the top 12 biotechnology destinations globally. In 2021, the country witnessed a significant surge in biotech startup registrations, with approximately 1,128 new startups registered-the highest in a single year since 2015. By the end of 2021, the total number of biotechnology startups reached 5,365, with projections suggesting this figure will rise to 10,000 by 2024. India is home to 665 FDA-approved plants in the U.S., accounts for 44% of global abbreviated new drug applications (ANDA), and has over 1,400 manufacturing plants meeting WHO standards. Also, India is the world's third-largest producer of the recombinant Hepatitis B vaccine.

Key Market Players

• Kerry Logistics Network Limited
• Deutsche Post AG
• DHL Group
• Kuehne + Nagel International AG
• UPS (Marken) Inc.
• DB Schenker
• FedEx Corp
• Nippon Express Co Ltd
• World Courier Inc
• SF Express

Report Scope:

In this report, the Global Bio-Pharma Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Pharma Logistics Market, By Service:

• Transportation
• Warehousing and Distribution
• Value Added Services

Bio-Pharma Logistics Market, By Type of Operation:

• Cold Chain
• Non-cold Chain

Bio-Pharma Logistics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-Pharma Logistics Market.

Available Customizations:

Global Bio-Pharma Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bio-Pharma Logistics Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Service (Transportation, Warehousing and Distribution, Value Added Services)
  • 4.2.2. By Type of Operation (Cold Chain, Non-cold Chain)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Service
  • 4.3.2. By Type of Operation
  • 4.3.3. By Region

5. Asia Pacific Bio-Pharma Logistics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service
  • 5.2.2. By Type of Operation
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Bio-Pharma Logistics Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Service
      • 5.3.1.2.2. By Type of Operation
  • 5.3.2. India Bio-Pharma Logistics Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Service
      • 5.3.2.2.2. By Type of Operation
  • 5.3.3. Australia Bio-Pharma Logistics Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Service
      • 5.3.3.2.2. By Type of Operation
  • 5.3.4. Japan Bio-Pharma Logistics Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Service
      • 5.3.4.2.2. By Type of Operation
  • 5.3.5. South Korea Bio-Pharma Logistics Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Service
      • 5.3.5.2.2. By Type of Operation

6. Europe Bio-Pharma Logistics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Type of Operation
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Bio-Pharma Logistics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Type of Operation
  • 6.3.2. Germany Bio-Pharma Logistics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Type of Operation
  • 6.3.3. Spain Bio-Pharma Logistics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Type of Operation
  • 6.3.4. Italy Bio-Pharma Logistics Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Service
      • 6.3.4.2.2. By Type of Operation
  • 6.3.5. United Kingdom Bio-Pharma Logistics Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Service
      • 6.3.5.2.2. By Type of Operation

7. North America Bio-Pharma Logistics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Type of Operation
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Bio-Pharma Logistics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Type of Operation
  • 7.3.2. Mexico Bio-Pharma Logistics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Type of Operation
  • 7.3.3. Canada Bio-Pharma Logistics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Type of Operation

8. South America Bio-Pharma Logistics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Type of Operation
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Bio-Pharma Logistics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Type of Operation
  • 8.3.2. Argentina Bio-Pharma Logistics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Type of Operation
  • 8.3.3. Colombia Bio-Pharma Logistics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Type of Operation

9. Middle East and Africa Bio-Pharma Logistics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Type of Operation
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Bio-Pharma Logistics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Type of Operation
  • 9.3.2. Saudi Arabia Bio-Pharma Logistics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Type of Operation
  • 9.3.3. UAE Bio-Pharma Logistics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Type of Operation
  • 9.3.4. Egypt Bio-Pharma Logistics Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Service
      • 9.3.4.2.2. By Type of Operation

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Bio-Pharma Logistics Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Kerry Logistics Network Limited
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Deutsche Post AG
• 14.3. DHL Group
• 14.4. Kuehne + Nagel International AG
• 14.5. UPS (Marken) Inc.
• 14.6. DB Schenker
• 14.7. FedEx Corp.
• 14.8. Nippon Express Co Ltd
• 14.9. World Courier Inc.
• 14.10.SF Express

15. Strategic Recommendations

16. About Us & Disclaimer